Displaying 13 - 24 of 71
Viral Hepatitis
3

Gilead: “From Headlines To The Clinic: Expert Approaches To Patient Care in Hepatitis Delta” - EASL Congress 2023

View
Viral Hepatitis
5

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” - EASL Congress 2023

View
Viral Hepatitis
5

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” - EASL Congress 2023

View
Viral Hepatitis
5

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” - EASL Congress 2023

View
Viral Hepatitis
5

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Displaying 13 - 24 of 71